ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 324

$528K Total Retail Price of All Prescriptions

Rank: 93 out of 324

570 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 570 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 570 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 7,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
AMLODIPINE BESYLATE 428 402 1 4
SIMVASTATIN 385 359 2 1
LEVOTHYROXINE SODIUM 355 299 3 2
METOPROLOL SUCCINATE 254 224 4 17
ATORVASTATIN CALCIUM 229 214 5 12
OMEPRAZOLE 219 202 6 6
HYDROCHLOROTHIAZIDE 201 183 7 11
HYDROCODONE-ACETAMINOPHEN 199 188 S3 8 5
LISINOPRIL 175 169 9 3
CRESTOR 163 163 10 28
ZOLPIDEM TARTRATE 162 158 11 20
TAMSULOSIN HCL 139 139 12 26
LOSARTAN POTASSIUM 111 102 13 15
METFORMIN HCL 108 88 14 9
DICLOFENAC SODIUM 104 88 15 114
POTASSIUM CHLORIDE 101 79 16 8
TRAZODONE HCL 96 93 17 42
GABAPENTIN 96 96 17 13
ATENOLOL 95 92 19 18
ALENDRONATE SODIUM 95 94 19 24
FUROSEMIDE 94 84 21 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 56 22 35
ALLOPURINOL 83 83 23 27
SYNTHROID 83 78 23 30
GLIMEPIRIDE 83 67 23 37
RANITIDINE HCL 82 60 26 58
SERTRALINE HCL 78 64 27 23
NEXIUM 76 68 28 33
CLOPIDOGREL 75 66 29 38
PRAVASTATIN SODIUM 71 68 30 21
ESCITALOPRAM OXALATE 71 69 30 54
DONEPEZIL HCL 69 69 32 25
AZITHROMYCIN 69 59 32 48
CELEBREX 68 68 34 96
TRIAMTERENE-HCTZ 66 57 35 46
CITALOPRAM HBR 65 53 36 16
WARFARIN SODIUM 64 48 37 10
PLAVIX 63 58 38 63
CARVEDILOL 62 62 39 22
ZETIA 60 55 40 68
KLOR-CON M20 60 55 40 52
CYMBALTA 59 45 42 45
MELOXICAM 59 58 42 29
PREDNISONE 56 49 44 36
METFORMIN HCL ER 56 44 44 74
CIPROFLOXACIN HCL 56 54 44 55
TRAMADOL HCL 50 34 47 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.